Last reviewed · How we verify

NCT04037774

Comparision of Different Doses of Dexmedetomidine With Low Dose Bupivacaine in Selective Spinal Anesthesia.

Status unknown Phase 4 Last updated 21 August 2019
What this trial tests

Phase 4 trial testing Dexmedetomidine in Drug Effect in 75 participants. Status unknown.

Timeline
2 September 2019
Primary endpoint
1 November 2019
1 November 2019

Quick facts

Lead sponsorServices Institute of Medical Sciences, Pakistan
PhasePhase 4
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment75
Start date2 September 2019
Primary completion1 November 2019
Estimated completion1 November 2019
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Services Institute of Medical Sciences, Pakistan

Who can join

20 and older, male only, with Drug Effect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The charactereistics of a spinal block varies with the dose of local anaesthetic and the adjuvant used. Literature review did not show comparison of different doses of dexmedetomidine with low-dose bupivacaine in saddle block. The rationale of this study is to determine an optimum dose of dexmedetomidine which in combination with low dose bupivacaine would provide satisfactory block with hemodynamic stability. This would be beneficial for patients scheduled for turp, as these pts are mostly elderly with various comorbidities.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dexmedetomidine

Trials testing the same drug.

Other recruiting trials for Drug Effect

Currently open trials in the same condition.

Other Services Institute of Medical Sciences, Pakistan trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04037774.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing